Galapagos Nv
Clinical trials sponsored by Galapagos Nv, explained in plain language.
-
Experimental cell therapy GLPG5101 shows promise for Hard-to-Treat lymphoma
Disease control OngoingThis study tests an experimental treatment called GLPG5101 for people with B-cell non-Hodgkin lymphoma that has come back or not responded to standard therapy. The treatment is made from the patient's own immune cells and given as a one-time infusion. The study has two phases: th…
Phase: PHASE1, PHASE2 • Sponsor: Galapagos NV • Aim: Disease control
Last updated May 02, 2026 16:17 UTC
-
New pill aims to tame rare muscle disease
Disease control OngoingThis study tests an oral drug called GLPG3667 in 40 adults with dermatomyositis, a rare autoimmune disease that causes muscle weakness and skin rashes. Participants take the pill once daily for 24 weeks to see if it improves muscle strength, daily function, and disease activity. …
Phase: PHASE2 • Sponsor: Galapagos NV • Aim: Disease control
Last updated May 01, 2026 15:58 UTC